We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 0.09% | 1,652.50 | 1,652.50 | 1,653.00 | 1,661.50 | 1,650.00 | 1,656.50 | 471,685 | 11:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.80 | 67.99B |
TIDMGSK
RNS Number : 9474N
GlaxoSmithKline PLC
26 May 2020
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan -------------------------------------------------------- Period of return: From: 1 November 2019 To: 30 April 2020 ------------------------ ------------------------- ------ --------------------- Balance of unallotted securities under scheme(s) from previous return: 153,724 -------------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 370,000 -------------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): (388,348) -------------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 135,376 -------------------------------------------------------- Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares ------------------------------------------------------------- Period of return: From: 1 November 2019 To: 30 April 2020 ------------------------ --------------------------- ------- ----------------------- Balance of unallotted securities under scheme(s) from previous return: 835,095 ------------------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 ------------------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 581,004 ------------------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 254,091 ------------------------------------------------------------- Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline 2009 Share Option Plan - ADS ------------------------------------------------- Period of return: From: 1 November 2019 To: 30 April 2020 ------------------------ ---------------------- ----- ------------------ Balance of unallotted securities under scheme(s) from previous return: 5,391,416 ------------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 ------------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 698,736 ------------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 4,692,680 ------------------------------------------------- Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 ---------------
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 26 May 2020
Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline plc Share Save Plan 2012 --------------------------------------------- Period of return: From: 1 November 2019 To: 30 April 2020 ------------------------ -------------------- ----- ---------------- Balance of unallotted securities under scheme(s) from previous return: 2,145,812 --------------------------------------------- Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): 0 --------------------------------------------- Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): 698,407 --------------------------------------------- Equals: Balance under scheme(s) not yet issued/allotted at end of period: 1,447,405 --------------------------------------------- Name of contact: Victoria Whyte Telephone number of contact: 020 8047 5000 ---------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRDZGZKGVLGGZM
(END) Dow Jones Newswires
May 26, 2020 06:53 ET (10:53 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions